Innovation Institute Blog

Innovation Institute Entrepreneur in Residence Michael Hufford recently signed on as CEO of Pitt Spinout LyGenesis Inc. In this blog post he takes a tongue-in-cheek approach to give advice to investigators who are considering whether to leave academia to join a startup built around their discoveries.

Matt Kesinger stands outside the offices of Forest Devices in Pittsburgh’s along Fifth Avenue in Pittsburgh’s Uptown neighborhood with the company’s prototype stroke diagnosis device strapped to his shoulder.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.

A potential treatment for preventing fibrosis following a heart attack and for inhibiting the cell signaling that triggers cancer metastasis; a technology platform to prevent the buildup of biological materials, or foulants, on surfaces such as medical implants; and novel biological and chemical sensors based on carbon nanomaterials, have been selected as recipients of the Chancellor’s Innovation Commercialization Funds.